Interventions for valvular disease and heart failure

Incidence and clinical impact of infective endocarditis after transcatheter aortic valve implantation

EuroIntervention 2016;11:1180-1187 published online ahead of print February 2015. DOI: 10.4244/EIJY15M02_05

Manuel Martínez-Sellés
Manuel Martínez-Sellés1,2*, MD, PhD; Emilio Bouza1, MD, PhD; Pablo Díez-Villanueva1, MD, PhD; Maricela Valerio1, MD; María Carmen Fariñas3, MD, PhD; Antonio J. Muñoz-García4, MD, PhD; Josefa Ruiz-Morales4, MD; Juan Gálvez-Acebal5, MD; Isabel Antorrena6, MD; Jesús María de la Hera Galarza7, MD; Enrique Navas8, MD, PhD; Patricia Muñoz1, MD, PhD; on behalf of the GAMES study group
1. Hospital General Universitario Gregorio Marañón, Madrid, Spain; 2. Universidad Europea, Madrid, Spain; 3. Hospital Universitario Marqués de Valdecilla, Santander, Spain; 4. Hospital Clínico Universitario Virgen de la Victoria, Málaga, Spain; 5. Hospita

Aims: To describe the characteristics of infective endocarditis (IE) after transcatheter aortic valve implantation (TAVI).

Sign in to read and download the full article

Forgot your password?

No account yet?
Sign up for free!

Create my pcr account

Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from

aortic valveinfective endocarditistranscatheter aortic valve implantation
Interventions for valvular diseaseTAVI
Read next article
Percutaneous left atrial appendage occlusion in patients with non-valvular atrial fibrillation: implantation and up to four years follow-up of the AMPLATZER Cardiac Plug

Latest news